These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23170960)

  • 1. Structure based lead optimization approach in discovery of selective DPP4 inhibitors.
    Ghate M; Jain SV
    Mini Rev Med Chem; 2013 May; 13(6):888-914. PubMed ID: 23170960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
    Li N; Wang LJ; Jiang B; Li XQ; Guo CL; Guo SJ; Shi DY
    Eur J Med Chem; 2018 May; 151():145-157. PubMed ID: 29609120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
    Musoev A; Numonov S; You Z; Gao H
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
    Patel BD; Bhadada SV; Ghate MD
    Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 3H-imidazo[4,5-c]quinolin-4(5H)-ones as potent and selective dipeptidyl peptidase IV (DPP-4) inhibitors.
    Ikuma Y; Hochigai H; Kimura H; Nunami N; Kobayashi T; Uchiyama K; Furuta Y; Sakai M; Horiguchi M; Masui Y; Okazaki K; Sato Y; Nakahira H
    Bioorg Med Chem; 2012 Oct; 20(19):5864-83. PubMed ID: 22938786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review upon medicinal perspective and designing rationale of DPP-4 inhibitors.
    Kumar S; Mittal A; Mittal A
    Bioorg Med Chem; 2021 Sep; 46():116354. PubMed ID: 34428715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated Protocol to Design Potential Inhibitors of Dipeptidyl Peptidase- 4 (DPP-4).
    Pantaleão SQ; Philot EA; de Oliveira Almeida M; Lima AN; de Sairre MI; Scott AL; Honorio KM
    Curr Top Med Chem; 2020; 20(3):209-226. PubMed ID: 31878857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554.
    Maezaki H; Banno Y; Miyamoto Y; Moritoh Y; Asakawa T; Kataoka O; Takeuchi K; Suzuki N; Ikedo K; Kosaka T; Sasaki M; Tsubotani S; Tani A; Funami M; Yamamoto Y; Tawada M; Aertgeerts K; Yano J; Oi S
    Bioorg Med Chem; 2011 Aug; 19(15):4482-98. PubMed ID: 21741847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipeptidyl peptidase IV inhibitors as a potential target for diabetes: patent review (2015-2018).
    Hussain H; Abbas G; Green IR; Ali I
    Expert Opin Ther Pat; 2019 Jul; 29(7):535-553. PubMed ID: 31203700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in non-peptidomimetic dipeptidyl peptidase 4 inhibitors: medicinal chemistry and preclinical aspects.
    Liu Y; Hu Y; Liu T
    Curr Med Chem; 2012; 19(23):3982-99. PubMed ID: 22709010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?
    Juillerat-Jeanneret L
    J Med Chem; 2014 Mar; 57(6):2197-212. PubMed ID: 24099035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and Rational Design of Natural-Product-Derived 2-Phenyl-3,4-dihydro-2H-benzo[f]chromen-3-amine Analogs as Novel and Potent Dipeptidyl Peptidase 4 (DPP-4) Inhibitors for the Treatment of Type 2 Diabetes.
    Li S; Xu H; Cui S; Wu F; Zhang Y; Su M; Gong Y; Qiu S; Jiao Q; Qin C; Shan J; Zhang M; Wang J; Yin Q; Xu M; Liu X; Wang R; Zhu L; Li J; Xu Y; Jiang H; Zhao Z; Li J; Li H
    J Med Chem; 2016 Jul; 59(14):6772-90. PubMed ID: 27396490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in natural products as DPP-4 inhibitors.
    Gao Y; Zhang Y; Zhu J; Li B; Li Z; Zhu W; Shi J; Jia Q; Li Y
    Future Med Chem; 2015; 7(8):1079-89. PubMed ID: 26062402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4).
    Thornberry NA; Gallwitz B
    Best Pract Res Clin Endocrinol Metab; 2009 Aug; 23(4):479-86. PubMed ID: 19748065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of potent dipeptidyl peptidase IV (DPP-4) inhibitors by employing a strategy to form a salt bridge with Lys554.
    Maezaki H; Tawada M; Yamashita T; Banno Y; Miyamoto Y; Yamamoto Y; Ikedo K; Kosaka T; Tsubotani S; Tani A; Asakawa T; Suzuki N; Oi S
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3565-3571. PubMed ID: 28579121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plant dipeptidyl peptidase-IV inhibitors as antidiabetic agents: a brief review.
    Turdu G; Gao H; Jiang Y; Kabas M
    Future Med Chem; 2018 May; 10(10):1229-1239. PubMed ID: 29749760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of highly potent DPP-4 inhibitors by hybrid compound design based on linagliptin and alogliptin.
    Lai ZW; Li C; Liu J; Kong L; Wen X; Sun H
    Eur J Med Chem; 2014 Aug; 83():547-60. PubMed ID: 24996141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DPP-4 inhibitors: a patent review (2012 - 2014).
    Costante R; Stefanucci A; Carradori S; Novellino E; Mollica A
    Expert Opin Ther Pat; 2015 Feb; 25(2):209-36. PubMed ID: 25482888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, biological evaluation, and docking studies of (s)-phenylalanine derivatives with a 2-cyanopyrrolidine moiety as potent dipeptidyl peptidase 4 inhibitors.
    Liu Y; Wu Y; Wu H; Tang L; Wu P; Liu T; Hu Y
    Chem Biol Drug Des; 2013 Aug; 82(2):140-6. PubMed ID: 23530834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis and Biological Evaluation of Imidazo[1,2-a]pyridine Derivatives as Novel DPP-4 Inhibitors.
    Li Q; Zhou M; Han L; Cao Q; Wang X; Zhao L; Zhou J; Zhang H
    Chem Biol Drug Des; 2015 Oct; 86(4):849-56. PubMed ID: 25787859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.